Analyst Ratings for 10X Genomics (TXG)
TXG Rating Summary
TXG Price Target Summary
- Highest: $32.00 (Canaccord)
- Lowest: $17.00 (Jefferies)
- Average: $23.69
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.69 (-31.8%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Avg. $ Target:
$23.69 (-31.8%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/30/2026 | William Blair | Matt Larew | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
19.48 (34.76) |
78.44% | Details |
| 12/11/2025 | Citi | Patrick Donnelly | Downgrade | Neutral (Buy) |
18.00 (N/A) |
17.53 (34.76) |
98.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
